Business Update
DiagnoCure partner launches new prostate cancer test in Europe
Published in Gene Therapy Weekly, December 28th, 2006
Gen-Probe's PCA3 gene-based test detects the overexpression of PCA3 mRNA in urine. Studies have shown that, in greater than 95% of prostate cancer cases, PCA3 is 60 to 100-fold over-expressed in prostate cancer cells compared to normal cells, indicating that PCA3 may be a useful biomarker for prostate cancer.
Preliminary data show that the PCA3 assay is more specific to prostate cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-12-28)
More Articles from Gene Therapy Weekly
- Chronic Lymphocytic Leukemia
Lentigen wins U.S. NIH grant to develop a potential new therapy for CLL - Sexual & Reproductive Health
Gene therapy for erectile dysfunction shows promise in clinical trial - Breast Cancer Therapy
University of Lubeck details research in breast cancer therapy - Cancer Gene Therapy
Investigators at University of Colorado, Colorado Cancer Center have published new data on cancer gene therapy - Cancer Gene Therapy
Korea Institute of Radiological and Medical Science details research in cancer gene therapy - Cancer Gene Therapy
New cancer gene therapy research from Georgetown University, Lombardi Comprehensive Cancer Center outlined - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
